Subtype
Thyroid Gland Neoplasm
CI-CAN-00001600Explore in graph →
Non-malignant189 active trials10 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001600Explore in graph →
Clinical trials
891 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05247476 | Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients. | unknown | Phase 4 | 50 | Zhongshan Hospital Xiamen UniversityOTHER | 1 | Feb 18, 2022 | clinicaltrials |
| NCT02688608 | Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer | completed | Phase 2 | 6 | Saad A KhanOTHER | 1 | Feb 10, 2022 | clinicaltrials |
| 177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer |
| completed |
| Early Phase 1 |
| 8 |
| University Hospital, Basel, SwitzerlandOTHER |
| 1 |
| Feb 10, 2022 |
| clinicaltrials |
| NCT03397238 | Myeloid Cell Reprogramming in Thyroid Carcinoma | completed | — | 41 | Radboud University Medical CenterOTHER | 1 | Feb 9, 2022 | clinicaltrials |
| NCT02628535 | Safety Study of MGD009 in B7-H3-expressing Tumors | terminated | Phase 1 | 67 | MacroGenicsINDUSTRY | 3 | Feb 8, 2022 | clinicaltrials |
| NCT04952493 | Anlotinib or Penpulimab in Combination With RAI for DTC | unknown | Phase 2 | 42 | Peking Union Medical College HospitalOTHER | 1 | Jan 28, 2022 | clinicaltrials |
| NCT02731352 | Study of Apatinib in Patients With Differentiated Thyroid Cancer | completed | Phase 2 | 20 | Peking Union Medical College HospitalOTHER | 1 | Jan 20, 2022 | clinicaltrials |
| NCT05191927 | A Nomogram Model to Predict Central Lymphnode Metastasis in Thyroid Papillary Carcinoma | completed | — | 1,200 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jan 14, 2022 | clinicaltrials |
| NCT02878044 | Shared Decision Making in Patients With Thyroid Nodules | completed | N/A | 21 | Mayo ClinicOTHER | 1 | Jan 6, 2022 | clinicaltrials |
| NCT02178345 | Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer | completed | — | 123 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 8, 2021 | clinicaltrials |
| NCT05124938 | Assessment of CA 19-9 in Patients' With Thyroid Malignancies | unknown | — | 120 | Sohag UniversityOTHER | 1 | Nov 18, 2021 | clinicaltrials |
| NCT02041260 | A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting | unknown | Phase 2 | 43 | Thomas Jefferson UniversityOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT03139747 | UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone | suspended | Phase 2 | 5 | Thomas Jefferson UniversityOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT03838692 | Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer | withdrawn | Phase 2 | 0 | Antonio FojoOTHER | 0 | Oct 13, 2021 | clinicaltrials |
| NCT02764554 | Post-Marketing Surveillance of Lenvima in Korean Patients | completed | — | 132 | Eisai Korea Inc.INDUSTRY | 1 | Oct 7, 2021 | clinicaltrials |
| NCT05052359 | Aberrant Helix Pomatia Agglutinin Binding Glycan Expression in Follicular Thyroid Tumours | completed | — | 37 | National University Health System, SingaporeOTHER | 1 | Oct 1, 2021 | clinicaltrials |
| NCT03131206 | A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer | terminated | Phase 1 / Phase 2 | 5 | Dana-Farber Cancer InstituteOTHER | 1 | Sep 27, 2021 | clinicaltrials |
| NCT05054634 | Psycho-oncological Intervention Through Counselling in Patients With Differentiated Thyroid Cancer in Treatment With Radioiodine(COUNTHY) | completed | — | 75 | QuironsaludOTHER | 1 | Sep 23, 2021 | clinicaltrials |
| NCT03942380 | Cell-free Tumor DNA in Head and Neck Cancer Patients | unknown | N/A | 500 | Christian von BuchwaldOTHER | 1 | Sep 21, 2021 | clinicaltrials |
| NCT03392402 | Molecular Classifier for the Fine Needle-based Assessment of Malignancy Risk in Thyroid Nodules(ThyroPred-1) | completed | — | 599 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT03787121 | Estimation of Economic Consequences Linked With Different Care Management Pathways of Differentiated Thyroid Cancers(ECO-THYR) | completed | — | 361 | University Hospital, ToulouseOTHER | 1 | Aug 27, 2021 | clinicaltrials |
| NCT04853680 | Effect of Anti-adhesion Barrier on the Voice Quality After Thyroidectomy. | unknown | N/A | 80 | Inha University HospitalOTHER | 1 | Aug 25, 2021 | clinicaltrials |
| NCT04204928 | Pre-Approval Access Program (PAAP) for Pralsetinib (BLU-667) in Patients With Unresectable or Metastatic NSCLC or MTC | approved for marketing | — | — | Blueprint Medicines CorporationINDUSTRY | 0 | Aug 13, 2021 | clinicaltrials |
| NCT01208051 | Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer | completed | Phase 1 / Phase 2 | 127 | National Cancer Institute (NCI)NIH | 2 | Jul 15, 2021 | clinicaltrials |
| NCT03630120 | Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer | terminated | Phase 2 | 6 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jul 14, 2021 | clinicaltrials |
| NCT03174925 | Ultrasound Elastography in Imaging Patients With Thyroid Nodules | completed | N/A | 55 | Stanford UniversityOTHER | 1 | Jul 8, 2021 | clinicaltrials |
| NCT02862470 | Anaplastic Thyroid Cancer and Follicular Thyroid Cancer-derived Exosomal Analysis Via Treatment of Lovastatin and Vildagliptin and Pilot Prognostic Study Via Urine Exosomal Biological Markers in Thyroid Cancer Patients | completed | — | 22 | National Taiwan University HospitalOTHER | 0 | Jul 6, 2021 | clinicaltrials |
| NCT03463889 | Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer | terminated | Phase 2 | 12 | University of California, San FranciscoOTHER | 1 | Jun 29, 2021 | clinicaltrials |
| NCT00124527 | Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer | completed | Phase 2 | 35 | Eisai Inc.INDUSTRY | 6 | Jun 16, 2021 | clinicaltrials |
| NCT04916262 | Correlation Between TCM Syndrome Factors and TSH Changes of Thyroid Hormone Withdrawal Before Iodine Therapy in Postoperative Patients With Thyroid Cancer | unknown | — | 160 | Qianfoshan HospitalOTHER | 0 | Jun 16, 2021 | clinicaltrials |
| NCT04904159 | Scoring System for Thyroid Gland Pathologies | unknown | — | 300 | Dr. Lutfi Kirdar Kartal Training and Research HospitalOTHER_GOV | 1 | Jun 1, 2021 | clinicaltrials |
| NCT04051099 | Bilateral Superficial Cervical Plexus Block in Thyroid/Parathyroid Surgery | unknown | N/A | 52 | Mahidol UniversityOTHER | 1 | May 24, 2021 | clinicaltrials |
| NCT04883294 | Validation of the Diagnostic Accuracy of the Electronic Nose in the Detection of Thyroid Cancer | unknown | — | 1,500 | Maastricht University Medical CenterOTHER | 0 | May 12, 2021 | clinicaltrials |
| NCT03469310 | Minimizing Narcotic Analgesics After Endocrine Surgery | completed | Phase 4 | 126 | Minerva A Romero ArenasOTHER | 1 | May 11, 2021 | clinicaltrials |
| NCT04876287 | Salivary dysfuncTion After Radioiodine Treatment(START) | completed | — | 138 | French Nuclear Safety and Radiation Protection Authority (ASNR)OTHER_GOV | 1 | May 10, 2021 | clinicaltrials |
| NCT00704730 | Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer(EXAM) | completed | Phase 3 | 330 | ExelixisINDUSTRY | 24 | Apr 20, 2021 | clinicaltrials |
| NCT04309136 | Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer | unknown | Phase 2 | 13 | Fudan UniversityOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT03377829 | A Multicenter Trial of PLA vs. Surgery for Treating PTMC | unknown | N/A | 200 | WeiWei ZhanOTHER | 2 | Mar 19, 2021 | clinicaltrials |
| NCT04601298 | The Risk Stratification of Papillary Thyroid Cancer With AUS/FLUS by FNA | completed | — | 290 | Shanghai 10th People's HospitalOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04554680 | Clinical Trial in RAI-Refractory Thyroid Carcinoma Evaluating BRAF & MEK Blockade for Re-differentiation Therapy | unknown | Phase 2 | 5 | National University Hospital, SingaporeOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT03031639 | Khon Kaen University's Thyroidectomy Registry | completed | — | 98 | Khon Kaen UniversityOTHER | 1 | Feb 18, 2021 | clinicaltrials |
| NCT04760171 | Amyloid Proteins From Medullary Thyroid Cancer and Laryngeal Amyloidosis | unknown | — | 10 | The Leeds Teaching Hospitals NHS TrustOTHER | 0 | Feb 18, 2021 | clinicaltrials |
| NCT01270321 | Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer | completed | Phase 2 | 42 | Emory UniversityOTHER | 1 | Feb 17, 2021 | clinicaltrials |
| NCT01707056 | The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma | withdrawn | N/A | 0 | Medstar Health Research InstituteOTHER | 1 | Feb 17, 2021 | clinicaltrials |
| NCT03072160 | Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer | completed | Phase 2 | 17 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2021 | clinicaltrials |
| NCT02156362 | Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis) | unknown | N/A | 643 | Hospices Civils de LyonOTHER | 1 | Jan 29, 2021 | clinicaltrials |
| NCT01774279 | interNational Anaplastic Thyroid Cancer Tissue Bank and Database (iNATT)(iNATT) | unknown | — | 350 | Velindre NHS TrustOTHER_GOV | 2 | Jan 5, 2021 | clinicaltrials |
| NCT00514046 | Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer | completed | Phase 1 / Phase 2 | 17 | National Cancer Institute (NCI)NIH | 1 | Dec 22, 2020 | clinicaltrials |
| NCT02138214 | Central Neck Dissection in Patients With Clinical Node Negative Thyroid Cancer | completed | Phase 2 | 117 | University of Wisconsin, MadisonOTHER | 1 | Dec 21, 2020 | clinicaltrials |
Data updated 24 days agoSource updated Feb 18, 2022source: clinicaltrials